7-117611794-C-G
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PM2PM5PP3_StrongPP5
The NM_000492.4(CFTR):āc.3353C>Gā(p.Ser1118Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000106 in 1,610,154 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S1118F) has been classified as Pathogenic.
Frequency
Consequence
NM_000492.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFTR | NM_000492.4 | c.3353C>G | p.Ser1118Cys | missense_variant | 20/27 | ENST00000003084.11 | NP_000483.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFTR | ENST00000003084.11 | c.3353C>G | p.Ser1118Cys | missense_variant | 20/27 | 1 | NM_000492.4 | ENSP00000003084.6 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151748Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250416Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135354
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1458406Hom.: 0 Cov.: 30 AF XY: 0.0000110 AC XY: 8AN XY: 725724
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151748Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74080
ClinVar
Submissions by phenotype
Cystic fibrosis Uncertain:1Other:1
not provided, no classification provided | literature only | ClinVar Staff, National Center for Biotechnology Information (NCBI) | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Dec 24, 2017 | - - |
Bronchiectasis with or without elevated sweat chloride 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 02, 2023 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 22, 2024 | Variant summary: CFTR c.3353C>G (p.Ser1118Cys) results in a non-conservative amino acid change located in the ABC transporter type 1, transmembrane domain (IPR011527) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 250416 control chromosomes. c.3353C>G has been reported in the literature in at least one compound heterozygous individual affected with adult-diagnosed Cystic Fibrosis (e.g. Desai_2018) and in individuals affected with CF or congenital bilateral absence of the vas deferens without a reported second variant (e.g. Dorfman_2008, Dorfman_2009, Masica_2012). These data do not allow any conclusion about variant significance. One publication reports experimental evidence evaluating an impact on protein function, showing potential alterations of disulfide cross-linking in CFTR channels measured in a patch clamp recording study (e.g. Wang_2012), however, does not allow convincing conclusions about the variant effect in a clinical setting. A different variant located at the same codon (c.3353C>T, p.Ser1118Phe) has been classified as pathogenic, supporting a critical relevance of this residue to CFTR protein function. The following publications have been ascertained in the context of this evaluation (PMID: 29944384, 20059485, 18292811, 22573477, 22843683). ClinVar contains an entry for this variant (Variation ID: 53721). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at